Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Idoxifene antagonizes estrogen effects in reproductive tissues

Dec. 17, 1998

CP-336156 further characterized pharmacologically and pharmacokinetically at bone meeting

Dec. 17, 1998

Potent GH secretatogue series patented by Sumitomo

Dec. 17, 1998

Transkaryotic Therapies initiates phase II program for Fabry's disease

Dec. 17, 1998

Aradigm initiates U.S. phase II studies of AERx Diabetes Management System

Dec. 17, 1998

New antidiabetic agents from Yamanouchi have a dual mechanism of action

Dec. 16, 1998

Tularik, Knoll to collaborate on antiobesity R&D

Dec. 16, 1998

Next-generation SERM presented by Hoechst Marion Roussel

Dec. 15, 1998

Raloxifene evaluated for one year in established postmenopausal osteoporosis

Dec. 14, 1998

Japanese ACAT inhibitor is safe and effective in several animal species

Dec. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...